deltatrials
Completed PHASE4 INTERVENTIONAL 2-arm NCT02959970

Safety and Efficacy Trial of ACZONE (Dapsone) Gel, 7.5% in 9 to 11 Year-Old Patients With Acne Vulgaris

An Open-Label Phase 4 Safety and Efficacy Trial of ACZONE (Dapsone) Gel, 7.5% in 9 to 11 Year-Old Patients With Acne Vulgaris

Sponsor: Allergan

Conditions Acne Vulgaris
Interventions dapsone gel
Updated 13 times since 2017 Last updated: Feb 19, 2020 Started: Oct 31, 2016 Primary completion: Mar 9, 2018 Completion: Mar 9, 2018
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02959970, this PHASE4 trial focuses on Acne Vulgaris and remains completed. Sponsored by Allergan, it has been updated 13 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshot~Feb 2017 – ~Jun 2017 · 4 months · monthly snapshot~Jun 2017 – ~Jun 2018 · 12 months · monthly snapshot~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshot~Jul 2018 – ~Nov 2018 · 4 months · monthly snapshot~Nov 2018 – ~Jan 2019 · 2 months · monthly snapshot~Jan 2019 – ~Mar 2020 · 14 months · monthly snapshot~Mar 2020 – ~Apr 2020 · 31 days · monthly snapshot~Apr 2020 – ~Jan 2021 · 9 months · monthly snapshot~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshot~Sep 2025 – present · 12 months · monthly snapshot

Change History

13 versions recorded
  1. Sep 2025 — Present [monthly]

    Completed PHASE4

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE4

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE4

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE4

  5. Apr 2020 — Jan 2021 [monthly]

    Completed PHASE4

Show 8 earlier versions
  1. Mar 2020 — Apr 2020 [monthly]

    Completed PHASE4

  2. Jan 2019 — Mar 2020 [monthly]

    Completed PHASE4

  3. Nov 2018 — Jan 2019 [monthly]

    Completed PHASE4

  4. Jul 2018 — Nov 2018 [monthly]

    Completed PHASE4

    Status: RecruitingCompleted

  5. Jun 2018 — Jul 2018 [monthly]

    Recruiting PHASE4

  6. Jun 2017 — Jun 2018 [monthly]

    Recruiting PHASE4

  7. Feb 2017 — Jun 2017 [monthly]

    Recruiting PHASE4

  8. Jan 2017 — Feb 2017 [monthly]

    Recruiting PHASE4

    First recorded

Oct 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Allergan
  • Almirall, S.A.
Data source: Almirall, S.A.

For direct contact, visit the study record on ClinicalTrials.gov .